Author Archives: admin

– Student festival gets boost from real world scientists – SAN DIEGO, Calif., February 3, 2010. BioAtla, LLC, announced their continued support for the San Diego Science Festival, pledging both a monetary donation and a commitment to serve on the … Continue reading →

– Conditionally active biologics a centerpiece of the three year agreement – In a recent statement – dateline SAN DIEGO, January 19, 2010 – Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, … Continue reading →

– Femta/Lonza targeting Rheumatoid Arthritis treatment – BioAtla’s partner company, Femta Pharmaceuticals, recently announced an agreement with Lonza Group Ltd. In a joint release by Femta Pharmaceuticals and Lonza – dateline San Diego, CA / Basel, Switzerland, 15 December 2009 … Continue reading →

– Say hello to Comprehensive Integrated Antibody Optimization: CIAO! – SAN DIEGO, Calif., June 11, 2009. BioAtla, LLC, announced a system for optimizing proteins, including antibodies for maximal expression and physiological function, dubbing the system CIAO! The acronym stands for … Continue reading →

– Innovative full-length IgG library expressed in Mammalian cells – SAN DIEGO, Calif., May 24, 2008. BioAtla, LLC, announced the release of their proprietary fully human antibody library. HuAb-SD rapidly identifies antibodies for customer targets and reduces the time for … Continue reading →

– Ongoing collaboration to fuel growth of both companies – SAN DIEGO, Calif., May 10, 2008. BioAtla, LLC, has joined with Latterell Venture Partners to launch Femta Pharmaceuticals, an antibody development company. Femta’s initial drug pipeline was developed by BioAtla … Continue reading →

–  Biotech industry veteran to support company growth  – SAN DIEGO, Calif., January 18, 2008. BioAtla, LLC, announces the addition of Leslie A. Hickle, Ph.D. as Vice President of Business Development for the West Coast. Dr. Hickle brings to BioAtla … Continue reading →

– Introduction of ATLab™ technologies is company’s latest breakthrough – SAN DIEGO, Calif., June 10, 2007. BioAtla, LLC, today announced the release of a validated suite of tools to bioaccelerate™ antibody evolution and humanization of nonhuman antibodies. Coined ATLAb™, the … Continue reading →

– IP firm key contributor to business strategy, client satisfaction of BioAcceleration™ company – SAN DIEGO, Calif., April 6, 2007. Capia IP has been retained to provide business, licensing, legal options and intellectual property support for BioAtla’s BioAcceleration™ protein therapeutics … Continue reading →

- Company launched as sister company to BioDuro for protein therapeutics – SAN DIEGO, Calif., March 29, 2007. BioAtla announced that its operations in San Diego and Beijing will be the first to provide global contract services solely focused on … Continue reading →